Literature DB >> 1646055

Effects of metabolic inhibitors on endothelium-dependent and endothelium-independent vasodilatation of rat and rabbit aorta.

C J Weir1, I F Gibson, W Martin.   

Abstract

1. Basal release of endothelium-derived relaxing factor (EDRF) rendered endothelium-containing rings of rat aorta 4.7 fold less sensitive to the contractile actions of phenylephrine and depressed the maximum response when compared with endothelium-denuded rings. The responsiveness and maximum response to phenylephrine was, however, similar in rings of rabbit aorta with or without endothelium. 2. Rotenone (1 nM-0.1 microM), an inhibitor of oxidative phosphorylation, induced a profound, irreversible blockade of phenylephrine-induced tone in endothelium-containing and endothelium-denuded rings of rat aorta, but induced only slight inhibition of tone in rings of rabbit aorta. 3. 2-Deoxy glucose (10 mM), an inhibitor of glycolysis, had no effect on phenylephrine-induced contraction in endothelium-denuded rings of rat aorta, but inhibited reversibly the endothelium-dependent depression of contraction in endothelium containing rings. 2-Deoxy glucose had no effect on phenylephrine-induced contraction in rings of rabbit aorta with or without endothelium. 4. Rotenone (0.1 microM) inhibited acetylcholine-induced, endothelium-dependent relaxation of phenylephrine-contracted rings or rat and rabbit aorta. In endothelium-denuded rings of rat aorta, relaxation induced by glyceryl trinitrate of isoprenaline was also inhibited, but relaxation induced by 8-bromo cyclic GMP or dibutyryl cyclic AMP was not. Relaxation induced by verapamil on KCl-contracted, endothelium-denuded rings of rat aorta was also unaffected. 5. 2-Deoxy glucose (10 mM) inhibited acetylcholine-induced, endothelium-dependent relaxation of phenylephrine-contracted rings of rat and rabbit aorta. In endothelium-denuded rings of rat aorta, relaxation induced by glyceryl trinitrate and by isoprenaline was also inhibited, but relaxation induced by 8-bromo cyclic GMP or dibutyryl cyclic AMP was not. Relaxation induced by verapamil on KCIcontracted, endothelium-denuded rings of rat aorta was also unaffected. 6. These data suggest that in rabbit and in rat aorta, rotenone inhibits acetylcholine-induced relaxation by inhibiting EDRF production, and by depressing smooth muscle sensitivity to EDRF, respectively. They further suggest that 2-deoxy glucose inhibits acetylcholine-induced relaxation in both tissues by depressing the sensitivity to EDRF, probably as a result of reduced synthesis of cyclic GMP. The additional possibility that 2-deoxy glucose inhibits EDRF production warrants further investigation. 7. The blockade by 2-deoxy glucose of the endothelium-dependent depression of phenylephrine-induced tone in rat aorta probably reflects blockade of the actions of spontaneously released EDRF.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1646055      PMCID: PMC1917888          DOI: 10.1111/j.1476-5381.1991.tb12147.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.

Authors:  L J Ignarro; G M Buga; K S Wood; R E Byrns; G Chaudhuri
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

2.  The release of endothelium-derived relaxant factor is calcium dependent.

Authors:  C J Long; T W Stone
Journal:  Blood Vessels       Date:  1985

3.  Endothelium-dependent vasodilator-and nitrovasodilator-induced relaxation may be mediated through cyclic GMP formation and cyclic GMP-dependent protein phosphorylation.

Authors:  R M Rapoport; M B Draznin; F Murad
Journal:  Trans Assoc Am Physicians       Date:  1983

Review 4.  The role of endothelium in the responses of vascular smooth muscle to drugs.

Authors:  R F Furchgott
Journal:  Annu Rev Pharmacol Toxicol       Date:  1984       Impact factor: 13.820

5.  The nature of endothelium-derived vascular relaxant factor.

Authors:  T M Griffith; D H Edwards; M J Lewis; A C Newby; A H Henderson
Journal:  Nature       Date:  1984 Apr 12-18       Impact factor: 49.962

6.  Flow-dependent, endothelium-mediated dilation of epicardial coronary arteries in conscious dogs: effects of cyclooxygenase inhibition.

Authors:  J Holtz; U Förstermann; U Pohl; M Giesler; E Bassenge
Journal:  J Cardiovasc Pharmacol       Date:  1984 Nov-Dec       Impact factor: 3.105

7.  Vascular endothelial cells synthesize nitric oxide from L-arginine.

Authors:  R M Palmer; D S Ashton; S Moncada
Journal:  Nature       Date:  1988-06-16       Impact factor: 49.962

8.  Calcium- and endothelial-mediated vascular smooth muscle relaxation in rabbit aorta.

Authors:  H A Singer; M J Peach
Journal:  Hypertension       Date:  1982 May-Jun       Impact factor: 10.190

9.  Phosphorylation of myosin light chain kinase from vascular smooth muscle by cAMP- and cGMP-dependent protein kinases.

Authors:  D R Hathaway; M V Konicki; S A Coolican
Journal:  J Mol Cell Cardiol       Date:  1985-09       Impact factor: 5.000

10.  Nitric oxide from L-arginine stimulates the soluble guanylate cyclase in adrenal glands.

Authors:  M Palacios; R G Knowles; R M Palmer; S Moncada
Journal:  Biochem Biophys Res Commun       Date:  1989-12-15       Impact factor: 3.575

View more
  13 in total

1.  Effects of hypoxia and metabolic inhibitors on production of prostacyclin and endothelium-derived relaxing factor by pig aortic endothelial cells.

Authors:  J M Richards; I F Gibson; W Martin
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

2.  Analyzing isolated blood vessel contraction in multi-well plates.

Authors:  Ricardo Borges; David Díaz-Martín; José G Hernández-Jiménez; Manuel Rodríguez-Valido; Beatriz Beltrán
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-02-23       Impact factor: 3.000

Review 3.  Superoxide dismutases: role in redox signaling, vascular function, and diseases.

Authors:  Tohru Fukai; Masuko Ushio-Fukai
Journal:  Antioxid Redox Signal       Date:  2011-06-06       Impact factor: 8.401

4.  Intracellular ATP can regulate afferent arteriolar tone via ATP-sensitive K+ channels in the rabbit.

Authors:  J N Lorenz; J Schnermann; F C Brosius; J P Briggs; P B Furspan
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

5.  Novel signal transduction pathway mediating endothelium-dependent beta-adrenoceptor vasorelaxation in rat thoracic aorta.

Authors:  D W Gray; I Marshall
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

6.  Impaired contraction and relaxation in aorta from streptozotocin-diabetic rats: role of polyol pathway.

Authors:  N E Cameron; M A Cotter
Journal:  Diabetologia       Date:  1992-11       Impact factor: 10.122

7.  Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats.

Authors:  N E Cameron; M A Cotter; E K Maxfield
Journal:  Diabetologia       Date:  1993-04       Impact factor: 10.122

8.  Mitochondria-targeted antioxidant (MitoQ) ameliorates age-related arterial endothelial dysfunction in mice.

Authors:  Rachel A Gioscia-Ryan; Thomas J LaRocca; Amy L Sindler; Melanie C Zigler; Michael P Murphy; Douglas R Seals
Journal:  J Physiol       Date:  2014-03-24       Impact factor: 5.182

9.  Inorganic Nitrite Supplementation Improves Endothelial Function With Aging: Translational Evidence for Suppression of Mitochondria-Derived Oxidative Stress.

Authors:  Matthew J Rossman; Rachel A Gioscia-Ryan; Jessica R Santos-Parker; Brian P Ziemba; Kara L Lubieniecki; Lawrence C Johnson; Natalie E Poliektov; Nina Z Bispham; Kayla A Woodward; Erzsebet E Nagy; Nathan S Bryan; Julie A Reisz; Angelo D'Alessandro; Michel Chonchol; Amy L Sindler; Douglas R Seals
Journal:  Hypertension       Date:  2021-03-01       Impact factor: 10.190

10.  Distinct Pharmacological Properties of Gaseous CO and CO-Releasing Molecule in Human Platelets.

Authors:  Patrycja Kaczara; Kamil Przyborowski; Tasnim Mohaissen; Stefan Chlopicki
Journal:  Int J Mol Sci       Date:  2021-03-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.